The Latest Life Sciences Tools & Diagnostics Articles from Streetwise Reports
New York Healthcare Technology Co. Discovers Scalable Behavioral Health Breakthrough
Biotech Firm Advances Voice-Based Intoxication Tech Aiming to Revolutionize Medical Diagnostics
Canadian Biotech Co. Appoints Elite Regulatory Expert for Chile Expansion
This article is issued on behalf of MindBio Therapeutics Corp. The World's First AI Voice Detection For Drugs & Alcohol With Charts That Beckon Investors To Buy
Contributed Technical Analyst Opinion 
Technical Analyst Stewart Thomson explains why he thinks MindBio Therapeutics Corp. (MBIO:CSE; MBQIF:OTCQB; WF6:Frankfurt) is a Speculative Buy.
First US Brain-Only PET Clinic Targets Alzheimer's Detection as Diagnostic Demand Expands
This article is issued on behalf of Grey Matters Health Inc. America's First Brain-Dedicated PET Scanning Clinics: A Turnaround Play for Chart-Savvy Investors?
Contributed Technical Analyst Opinion 
Technical Analyst Stewart Thomson explains why he thinks Algernon Health (AGN:CSE; AGNPF:OTCQB; AGW0:XFRA) is a Strong Speculative Buy.
Biotech Company Accelerates AI Detection Breakthrough Globally
ThinkEquity Morning Briefing: Complacency Is Creating a Dangerous Market
Think Equity shares its morning brief, including macro insights and upgrades and downgrades of key stocks. This article is issued on behalf of Rocket Doctor AI Inc. An AI-Powered Doctor & Patient Platform: Why This North American Provider is Gaining Market Momentum
Contributed Technical Analyst Opinion 
Technical Analyst Stewart Thomson explains why he likes Rocket Doctor AI Inc. (AIDR:CSE; TREIF:OTC; 939:FRA).
Biotech Expands Financing to CA$2M as AI-Driven Cancer Drug Programs Advance
Showing Results: 26 to 35 of 35 Prev
© 2026 Streetwise Reports. All rights reserved.
Streetwise Reports is registered with the U.S. Patent and Trademark Office.
